What is the efficacy of implantable cardioverter-defibrillator (ICD) therapy for women?

Updated: Feb 13, 2017
  • Author: Daniel M Beyerbach, MD, PhD; Chief Editor: Jeffrey N Rottman, MD  more...
  • Print
Answer

Answer

Women enrolled in primary prevention ICD trials have had the same mortality compared with men, while experiencing significantly fewer appropriate ICD interventions, thus suggesting a smaller impact of sudden cardiac death on overall mortality in women with dilated cardiomyopathy. [24]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!